457 related articles for article (PubMed ID: 27912971)
21. Two cycles of neoadjuvant chemotherapy improves survival in patients with high-risk upper tract urothelial carcinoma.
Zennami K; Sumitomo M; Takahara K; Nukaya T; Takenaka M; Fukaya K; Ichino M; Fukami N; Sasaki H; Kusaka M; Shiroki R
BJU Int; 2021 Mar; 127(3):332-339. PubMed ID: 32896105
[TBL] [Abstract][Full Text] [Related]
22. Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma.
Margulis V; Puligandla M; Trabulsi EJ; Plimack ER; Kessler ER; Matin SF; Godoy G; Alva A; Hahn NM; Carducci MA; Hoffman-Censits J;
J Urol; 2020 Apr; 203(4):690-698. PubMed ID: 31702432
[TBL] [Abstract][Full Text] [Related]
23. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
Seisen T; Peyronnet B; Dominguez-Escrig JL; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Cowan NC; Kaasinen E; Palou J; van Rhijn BW; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
Eur Urol; 2016 Dec; 70(6):1052-1068. PubMed ID: 27477528
[TBL] [Abstract][Full Text] [Related]
24. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
[TBL] [Abstract][Full Text] [Related]
25. Trends in management of ureteral urothelial carcinoma and effects on survival: a hospital-based registry study.
Lec PM; Venkataramana A; Lenis AT; Fero KE; Sharma V; Golla V; Gollapudi K; Blumberg J; Chamie K
Urol Oncol; 2021 Mar; 39(3):194.e17-194.e24. PubMed ID: 33012575
[TBL] [Abstract][Full Text] [Related]
26. Site of metastatic recurrence impacts prognosis in patients with high-grade upper tract urothelial carcinoma.
Cheaib JG; Claus LE; Patel HD; Kates MR; Matoso A; Hahn NM; Bivalacqua TJ; Hoffman-Censits JH; Pierorazio PM
Urol Oncol; 2021 Jan; 39(1):74.e9-74.e16. PubMed ID: 33071108
[TBL] [Abstract][Full Text] [Related]
27. The De Ritis (aspartate transaminase/alanine transaminase) ratio as a predictor of oncological outcomes in patients after surgery for upper urinary tract urothelial carcinoma.
Cho YH; Hwang JE; Chung HS; Kim MS; Hwang EC; Jung SI; Kang TW; Kwon DD; Choi SH; Kim HT; Kim TH; Kwon TG; Noh JH; Kim MK; Kim CS; Kang SG; Kang SH; Cheon J; Lee CH; Ku JY; Ha HK; Tae BS; Jeong CW; Ku JH; Kwak C; Kim HH
Int Urol Nephrol; 2017 Aug; 49(8):1383-1390. PubMed ID: 28484945
[TBL] [Abstract][Full Text] [Related]
28. Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelines.
Upfill-Brown A; Lenis AT; Faiena I; Salmasi AH; Johnson DC; Pooli A; Drakaki A; Gollapudi K; Blumberg J; Pantuck AJ; Chamie K
World J Urol; 2019 Jun; 37(6):1157-1164. PubMed ID: 30267197
[TBL] [Abstract][Full Text] [Related]
29. Impact of bacillus Calmette-Guérin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomy.
Horiguchi H; Yoneyama T; Hatakeyama S; Tokui N; Sato T; Fujita N; Yamamoto H; Tobisawa Y; Yoneyama T; Hashimoto Y; Koie T; Yoshikawa K; Narita S; Kawaguchi T; Ohyama C
Med Oncol; 2018 Feb; 35(4):41. PubMed ID: 29480348
[TBL] [Abstract][Full Text] [Related]
30. Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma.
Pradere B; D'Andrea D; Schuettfort VM; Foerster B; Quhal F; Mori K; Abufaraj M; Margulis V; Deuker M; Briganti A; Muilwijk T; Hendricksen K; Lotan Y; Karakiewic P; F Shariat S;
World J Urol; 2021 Jul; 39(7):2567-2577. PubMed ID: 33067726
[TBL] [Abstract][Full Text] [Related]
31. Predictors for Intravesical Recurrence Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A National Multicenter Analysis.
Lee CH; Ku JY; Jeong CW; Ku JH; Kwak C; Kim HH; Tae BS; Choi SH; Kim HT; Kim TH; Kwon TG; Hwang EC; Jung SI; Kang TW; Kwon DD; Ha HK
Clin Genitourin Cancer; 2017 Dec; 15(6):e1055-e1061. PubMed ID: 28802888
[TBL] [Abstract][Full Text] [Related]
32. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease.
Gakis G; Schubert T; Alemozaffar M; Bellmunt J; Bochner BH; Boorjian SA; Daneshmand S; Huang WC; Kondo T; Konety BR; Laguna MP; Matin SF; Siefker-Radtke AO; Shariat SF; Stenzl A
World J Urol; 2017 Mar; 35(3):327-335. PubMed ID: 27043218
[TBL] [Abstract][Full Text] [Related]
33. Urothelial carcinoma of the bladder and the upper tract: disparate twins.
Green DA; Rink M; Xylinas E; Matin SF; Stenzl A; Roupret M; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2013 Apr; 189(4):1214-21. PubMed ID: 23023150
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma.
Liao RS; Gupta M; Schwen ZR; Patel HD; Kates M; Johnson MH; Hahn NM; McConkey D; Bivalacqua TJ; Pierorazio PM
J Urol; 2018 Jul; 200(1):68-73. PubMed ID: 29307680
[TBL] [Abstract][Full Text] [Related]
35. The effect of contralateral kidney volume on renal function after radical nephroureterectomy: Implications for eligibility for neoadjuvant chemotherapy for upper tract urothelial cancer.
Song W; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
Urol Oncol; 2017 Mar; 35(3):114.e1-114.e7. PubMed ID: 27908680
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of Adjuvant Chemotherapy in Variant Histology Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy: Stabilized Inverse Probability Treatment Weighting Analysis of Single Center Experience.
Park I; Suh J; Lim B; Song C; You D; Jeong IG; Hong JH; Ahn H; Cho YM; Lee J; Hong B
Clin Genitourin Cancer; 2024 Jun; 22(3):102069. PubMed ID: 38580522
[TBL] [Abstract][Full Text] [Related]
37. Impact of adjuvant chemotherapy in patients with upper tract urothelial carcinoma and lymphovascular invasion after radical nephroureterectomy.
Lee KS; Kim KH; Yoon YE; Choi KH; Yang SC; Han WK
Korean J Urol; 2015 Jan; 56(1):41-7. PubMed ID: 25598935
[TBL] [Abstract][Full Text] [Related]
38. Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M; Schubert T; Xylinas E; Kluth L; Rouprêt M; Trinh QD; Lee RK; Al Hussein Al Awamlh B; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Bachmann A; Shariat SF;
Eur J Surg Oncol; 2014 Dec; 40(12):1693-9. PubMed ID: 24780094
[TBL] [Abstract][Full Text] [Related]
39. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M;
BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
[TBL] [Abstract][Full Text] [Related]
40. Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma.
Nazzani S; Preisser F; Mazzone E; Marchioni M; Bandini M; Tian Z; Mistretta FA; Shariat SF; Soulières D; Saad F; Montanari E; Luzzago S; Briganti A; Carmignani L; Karakiewicz PI
Clin Genitourin Cancer; 2019 Jun; 17(3):e602-e611. PubMed ID: 31005472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
